Hiroshi Takashima Selected Research

Hiroshi Takashima Research Topics

Disease

15	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 11/2023 - 02/2002
7	Cerebellar Ataxia (Dysmetria) 12/2023 - 01/2018
5	Peripheral Nervous System Diseases (PNS Diseases) 12/2023 - 02/2002
5	Muscle Weakness 09/2023 - 01/2014
5	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 05/2013
5	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2020 - 08/2003
5	Paralysis (Palsy) 12/2014 - 01/2011
3	Brain Diseases (Brain Disorder) 01/2024 - 10/2017
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 12/2023 - 10/2002
3	Neoplasms (Cancer) 11/2023 - 04/2011
3	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 10/2023 - 06/2002
3	Seizures (Absence Seizure) 01/2023 - 11/2013
3	Thrombosis (Thrombus) 01/2023 - 12/2018
3	Channelopathies 12/2022 - 01/2012
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2022 - 02/2014
3	Leukocytosis (Pleocytosis) 01/2018 - 08/2003
3	Atrophy 01/2018 - 01/2013
3	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2018 - 08/2013
3	Dementia (Dementias) 01/2018 - 04/2015
3	Inflammation (Inflammations) 01/2017 - 08/2003
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017 - 05/2013
3	Cerebral Infarction 01/2014 - 08/2003
3	Neoplasm Metastasis (Metastasis) 04/2011 - 08/2002
2	Guillain-Barre Syndrome 10/2023 - 12/2020
2	1 X-linked Charcot-Marie-Tooth disease 10/2023 - 05/2018
2	Parkinsonian Disorders (Parkinsonism) 09/2023 - 10/2018
2	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 01/2017
2	Ischemic Stroke 10/2022 - 01/2014
2	Stroke (Strokes) 10/2022 - 07/2019
2	Myelitis 04/2022 - 08/2003
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2020 - 11/2013
2	Respiratory Insufficiency (Respiratory Failure) 07/2020 - 12/2017
2	Parkinson Disease (Parkinson's Disease) 10/2018 - 04/2015
2	Cognitive Dysfunction 10/2018 - 06/2014
2	Multiple Sclerosis 12/2017 - 08/2003
2	Disease Progression 12/2016 - 01/2014
2	Type 2D Charcot-Marie-Tooth disease 12/2016 - 01/2014
2	Encephalitis (Encephalitis, Rasmussen) 11/2016 - 06/2014
2	Hypokinesia (Bradykinesia) 11/2014 - 01/2011
2	Nervous System Diseases (Neurological Disorders) 11/2013 - 11/2010
2	Myositis (Idiopathic Inflammatory Myopathies) 08/2012 - 09/2011
2	Adenocarcinoma 06/2012 - 08/2002
2	Lymphatic Metastasis 04/2011 - 04/2007
2	Early-Onset Glaucoma 11/2006 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2005 - 08/2002
2	Subacute Sclerosing Panencephalitis (SSPE) 10/2003 - 03/2003
1	Paraplegia (Spastic Paraplegia) 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Paroxysmal Extreme Pain Disorder 12/2023
1	Erythromelalgia (Erythermalgia) 12/2023
1	Cyanosis 11/2023
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 11/2023
1	Microscopic Polyangiitis 11/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2002
5	AntibodiesIBA 01/2023 - 11/2013
5	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018 - 09/2011
4	Intravenous Immunoglobulins (IVIG)FDA Link 11/2023 - 04/2013
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2018
4	periaxinIBA 12/2021 - 02/2002
3	MMEIBA 11/2023 - 04/2016
3	EnzymesIBA 05/2023 - 10/2002
3	Myelin P0 Protein (Myelin Protein Zero)IBA 01/2021 - 02/2002
3	Immunoglobulin G (IgG)IBA 12/2020 - 08/2003
3	AntigensIBA 09/2020 - 08/2002
3	AutoantibodiesIBA 01/2017 - 11/2013
2	Neprilysin (Neutral Endopeptidase)IBA 11/2023 - 01/2017
2	Codon (Codons)IBA 10/2023 - 06/2014
2	ConnexinsIBA 10/2023 - 04/2013
2	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 10/2018
2	SteroidsIBA 01/2023 - 11/2016
2	Cholinergic ReceptorsIBA 01/2023 - 10/2017
2	Monoclonal AntibodiesIBA 01/2023 - 05/2013
2	Ion Channels (Ion Channel)IBA 12/2022 - 01/2012
2	AnticoagulantsIBA 10/2022 - 07/2019
2	Prion ProteinsIBA 05/2021 - 01/2013
2	PrionsIBA 05/2021 - 08/2003
2	Glutamate Receptors (Glutamate Receptor)IBA 09/2020 - 06/2014
2	N-Methylaspartate (NMDA)IBA 09/2020 - 06/2014
2	Phosphotransferases (Kinase)IBA 02/2019 - 10/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2017
2	Gap Junction beta-1 ProteinIBA 05/2018 - 02/2002
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2018 - 08/2013
2	Trans-Activators (Trans-Acting Factor)IBA 12/2017 - 05/2013
2	Carrier Proteins (Binding Protein)IBA 06/2017 - 08/2012
2	Immunoglobulins (Immunoglobulin)IBA 06/2017 - 01/2017
2	Glycine-tRNA LigaseIBA 12/2016 - 01/2014
2	Surface Antigens (Surface Antigen)IBA 06/2014 - 11/2013
2	Cadherins (E-Cadherin)IBA 06/2012 - 04/2011
2	Myelin ProteinsIBA 02/2012 - 02/2002
2	Nonsense Codon (Nonsense Mutation)IBA 11/2006 - 01/2006
1	4-Hydroxyphenylpyruvate DioxygenaseIBA 01/2024
1	protein kinase C gamma (PRKCG)IBA 12/2023
1	Voltage-Gated Sodium ChannelsIBA 12/2023
1	fibroblast growth factor 14IBA 11/2023
1	GlucocorticoidsIBA 11/2023

Therapy/Procedure

13	Therapeutics 01/2023 - 08/2002
2	Immunotherapy 10/2023 - 02/2014
2	Tracheostomy 07/2020 - 01/2013
2	Intravenous Injections 09/2003 - 08/2002
1	Transplantation 11/2023